Arcturus Therapeutics Holdings Inc. Stock price
Equities
ARCT
US03969T1097
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.77 USD | +2.77% | +1.93% | +7.10% |
Financials (USD)
Sales 2024 * | 151M | Sales 2025 * | 254M | Capitalization | 909M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | 2M | EV / Sales 2024 * | 3.62 x |
Net cash position 2024 * | 364M | Net cash position 2025 * | - | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
207
x | Employees | 180 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.19% |
Latest transcript on Arcturus Therapeutics Holdings Inc.
1 day | +2.77% | ||
1 week | +1.93% | ||
Current month | -12.87% | ||
1 month | -15.95% | ||
3 months | +2.43% | ||
6 months | +32.74% | ||
Current year | +7.10% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 13-02-28 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 19-08-31 |
Chief Tech/Sci/R&D Officer | - | 21-10-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward W. Holmes
BRD | Director/Board Member | 83 | 19-08-31 |
James F. Barlow
BRD | Director/Board Member | 65 | 18-05-26 |
Peter Farrell
CHM | Chairman | 81 | 18-05-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 33.77 | +2.77% | 527,839 |
24-03-27 | 32.86 | +2.27% | 867,781 |
24-03-26 | 32.13 | -7.65% | 554,648 |
24-03-25 | 34.79 | +2.63% | 800,820 |
24-03-22 | 33.9 | +2.32% | 327,396 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.10% | 909M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |